Labeled FISH probes for identification of gene translocation using Fluorescent In Situ Hybridization Technique. (Technology)
Form:
Liquid
Quality Control Testing:
Representative images of normal human cell (lymphocyte) stain with the dual color FISH probe. The left image is chromosomes at metaphase, and the right image is an interphase nucleus.
Supplied Product:
DAPI Counterstain (1500 ng/mL ) 125 uL for each 100 uL FISH Probe
Storage Instruction:
Store at 4°C in the dark.
Note:
Hybridization position of the probes on the chromosome.
Probe 1:Size:Fluorophore:Location:
BCRApproximately 1520kbFITC22q11.23
Probe 2:Size:Fluorophore:Location:
ABL Approximately 780kbTexas Red9q34.1
Notice:
We strongly recommend the customer to use FFPE FISH PreTreatment Kit 1 (Catalog #: KA2375 or KA2691) for the pretreatment of Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections.
Regulation Status:
For research use only (RUO)
Datasheet:
Download
Applications
Fluorescent In Situ Hybridization (Cell)
Protocol Download
Fluorescent In Situ Hybridization (Formalin/PFA-fixed paraffin-embedded sections)
enlarge this image
Human lymph node (FFPE) stained with bcr/abl DY Translocation FISH Probe. Human lymph node cancer showed no bcr/abl DY Translocation.
Protocol Download
Fluorescent In Situ Hybridization (Formalin/PFA-fixed paraffin-embedded sections)
enlarge this image
Human CML (FFPE) stained with bcr/abl DY Translocation FISH Probe. Human CML showed bcr/abl gene translocation.
Protocol Download
Application Image
Fluorescent In Situ Hybridization (Cell)
Fluorescent In Situ Hybridization (Formalin/PFA-fixed paraffin-embedded sections)
enlarge
Fluorescent In Situ Hybridization (Formalin/PFA-fixed paraffin-embedded sections)
enlarge
ABL1
BCR
Gene Information
Entrez GeneID:
613
Gene Name:
BCR
Gene Alias:
ALL,BCR-ABL1,BCR1,CML,D22S11,D22S662,FLJ16453,PHL
Gene Description:
breakpoint cluster region
Omim ID:
151410, 608232
Gene Ontology:
Hyperlink
Gene Summary:
A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq
Other Designations:
bcr-abl1 e14a3 chimeric protein
Gene Information
Entrez GeneID:
25
Gene Name:
ABL1
Gene Alias:
ABL,JTK7,bcr/abl,c-ABL,p150,v-abl
Gene Description:
c-abl oncogene 1, receptor tyrosine kinase
Omim ID:
189980
Gene Ontology:
Hyperlink
Gene Summary:
The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response.Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene.The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia.The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1.The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq